Clinical Trial Update: A Study of Imatinib With Reinduction Chemotherapy Using Mitoxantrone, Etoposide and Cytarabine in Patients With Relapsed/Refractory C-kit Positive (AML) Acute Myeloid Leukemia [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 study evaluating the combination of imatinib with reinduction chemotherapy (mitoxantrone, etoposide, cytarabine) in relapsed/refractory C-kit positi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Gleevec (Imatinib)
• Novantrone (mitoxantrone)
• Toposar (Etoposide)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Leukemia | Phase 1, Phase 2 | Status: COMPLETED